Author

Arash Jamalian

Observed names: A. Jamalian, Jamalian, Arash

Institutions: Stanford Medicine, Stanford University

Observed institutions: Stanford Medicine, Stanford University

OpenAlex ID: A5001256729

Radiomic Signature Predicts Tumor Progression and Survival Outcomes in Pancreatic Cancer Patients Undergoing Stereotactic Body Radiation Therapy (SBRT)

2025 · Q. Xu, D.A.S. Toesca, et al. · International Journal of Radiation Oncology*Biology*Physics

Clinico-radiographic predictors of overall survival in stage II-III pancreatic cancer.

2025 · Qinmei Xu, Diego Toesca, et al. · Journal of Clinical Oncology

Clinical determinants of survival in patients with stage II-III pancreatic cancer.

2024 · Haruka Itakura, Qinmei Xu, et al. · Journal of Clinical Oncology

Utility of radiomic features in predicting clinical outcomes in stage II-III pancreatic cancer.

2024 · Haruka Itakura, Qinmei Xu, et al. · Journal of Clinical Oncology

Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.

2024 · Qinmei Xu, Diego Augusto Santos Toesca, et al. · Journal of Clinical Oncology

Works count: 6

Citation count:

H-index:

I10-index: